Research Studies

Current Clinical Trials:

Study: Evaluation of the Mind.Px Patch on Response to Biologic Treatment for Patients with Plaque Psoriasis

Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.

Qualifications:

• Male and Females, 18 years or older
• Current diagnosis of Plaque Psoriasis

Duration: Up to 20 weeks

Location: Hackensack, NJ

Compensation: Up to $630 will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Evaluation of Dermal Cooling System for the Treatment of Psoriasis

Purpose: The purpose of this investigation is to evaluate the Dermal Cooling System for the treatment of Psoriasis in adult subjects, to verify that exposure to controlled cold conditions will elicit improvement in the cosmetic appearance or physical symptoms of patients affected by this skin condition.

Qualifications:

• Males and females, ages 18 or older
• Psoriasis diagnosis (if no diagnosis, can be diagnosed on site)
• Subject is willing to have skin exposed to cooling with Dermal Cooling System

Duration: Approximately 12 months

Location: Hackensack, NJ

Compensation: $50 per visit

Interested in participating in our clinical research study? Please click here.

---

Study: Efficacy and Safety study of RPT193 as Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis

Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.

Qualifications:

• Male and Females, 18 to 75 years old
• Clinical diagnosis of Atopic Dermatitis
• Documented history of inadequate response to a ≥1 month treatment with topical medications

Duration: Up to 7 months

Location: Hackensack, NJ

Compensation: Up to $650

Interested in participating in our clinical research study? Please click here.

---

Study: Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Combination With Topical Corticosteroids and/or Topical Calcineurin Inhibitors in Adult Subjects With Moderate-to-Severe Atopic Dermatitis

Purpose: This study is being done to evaluate the safety and tolerability of Rocatinlimab (AMG 451) in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in combination with topical corticosteroids/topical calcineurin inhibitor. This is a placebo-controlled, double-blind study.

Qualifications:

• Males and Females, ages 18 or older
• Clinical diagnosis of Atopic Dermatitis
• Documented history of inadequate response to topical corticosteroids within 6 months

Duration: Approximately 6 months

Location: Hackensack, NJ

Compensation: $30 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.

---

Study: Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate-to-Severe Pruritus in Adult Subjects with Atopic Dermatitis

Purpose: This study is being done to evaluate to evaluate the efficacy of 2 dose levels of oral difelikefalin as adjunct therapy to a topical corticosteroid (TCS), compared to placebo and to TCS alone, in reducing the intensity of itch after 12 weeks of treatment for moderate-to-severe pruritus in adult subjects with atopic dermatitis (AD).

Qualifications:

• Males and Females, between 18 – 80 years of age
• Clinical diagnosis of active Atopic Dermatitis
• Chronic pruritus related to Atopic Dermatitis

Duration: Approximately 4 months

Location: Hackensack, NJ

Compensation: $68 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.